Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday.
Interacting with students at the India International Science Festival in Bhopal, Ella also said that the homegrown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.
"Our nasal vaccine will be officially launched on January 26, on Republic Day," Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Featured Video Of The Day
Government Vs Opposition: Who Owns Ambedkar?
Covid mRNA Vaccines Contributing To Deaths, Doctors Call For Suspension Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent Covid Vaccinated Pregnant Women At Lower Risk Of Caesarean Births: Study Naval Personnel Among 13 Killed As Navy Boat Collides With Ferry Near Mumbai World Leaders On Speed-Dial: How Elon Musk Is Causing Geopolitical Tremors Man Rapes 10-Year-Old Girl, Inserts Rod In Her Genitals: Gujarat Police 48-Year-Old Indian-origin Man Jailed For Life In UK For Mother's Murder "Alvida Yatra": Tejashwi Yadav's Jibe Ahead Of Nitish Kumar's Pragati Yatra 1 More Arrested In Crude Bomb Attack Outside Gurugram Clubs Track Latest News Live on NDTV.com and get news updates from India and around the world.